SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-068076
Filing Date
2024-06-04
Accepted
2024-06-04 09:25:25
Documents
5
Period of Report
2024-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2416321d1_6k.htm 6-K 22191
2 EXHIBIT 10.1 tm2416321d1_ex10-1.htm EX-10.1 33341
3 EXHIBIT 10.2 tm2416321d1_ex10-2.htm EX-10.2 32826
4 EXHIBIT 10.3 tm2416321d1_ex10-3.htm EX-10.3 64478
5 EXHIBIT 10.4 tm2416321d1_ex10-4.htm EX-10.4 63929
  Complete submission text file 0001104659-24-068076.txt   217917
Mailing Address NO. 152 HONGLIANG EAST 1ST STREET NO. 1703, TIANFU NEW DISTRICT CHENGDU F4 610200
Business Address NO. 152 HONGLIANG EAST 1ST STREET NO. 1703, TIANFU NEW DISTRICT CHENGDU F4 610200 86-0937-2689523
Qilian International Holding Group Ltd (Filer) CIK: 0001779578 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-39805 | Film No.: 241016236
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)